Axcelis

President and CEO Russell J. Low and CFO James G. Coogan lead a management team with deep industry experience. Governance and disclosure quality are solid, and execution on product roadmaps and CS&I expansion is evident. Risks include the complexity of integrating Veeco and managing high China exposure under evolving export controls.

On balance, leadership quality is above average with a disciplined focus on the core implant franchise.